Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in HTLV-1 Associated Neurological Disease
NCT01472263Phase 3Completed
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pentoxifylline in HTLV-1-associated myelopathy (HAM), neurogenic bladder, sponsored by Hospital Universitário Professor Edgard Santos. Started Sep 2009; status: completed.
02
Drugs
pentoxifylline
03
Conditions
HTLV-1-associated myelopathy (HAM)neurogenic bladder
Beyond the preview
Go deeper on NCT01472263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472263.